Evaluation of anti-microbial activity of spore powder of Ganoderma lucidum on clinical isolates of Prevotella intermedia: A pilot study

Aim: This study aimed at evaluating the anti-microbial activity of spore powder of Ganoderma lucidum on Prevotella intermedia isolated from subgingival plaque from chronic periodontitis patients. Settings and Design: Written informed consent was obtained from each subject enrolled in the study. The...

Full description

Bibliographic Details
Main Authors: Ranganath N Nayak, P T Dixitraj, Aarati Nayak, Kishore Bhat
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Contemporary Clinical Dentistry
Subjects:
Online Access:http://www.contempclindent.org/article.asp?issn=0976-237X;year=2015;volume=6;issue=6;spage=248;epage=252;aulast=Nayak
id doaj-31e0508b61804bc28359a16e059adb41
record_format Article
spelling doaj-31e0508b61804bc28359a16e059adb412020-11-25T00:40:35ZengWolters Kluwer Medknow PublicationsContemporary Clinical Dentistry0976-237X0976-23612015-01-016624825210.4103/0976-237X.166834Evaluation of anti-microbial activity of spore powder of Ganoderma lucidum on clinical isolates of Prevotella intermedia: A pilot studyRanganath N NayakP T DixitrajAarati NayakKishore BhatAim: This study aimed at evaluating the anti-microbial activity of spore powder of Ganoderma lucidum on Prevotella intermedia isolated from subgingival plaque from chronic periodontitis patients. Settings and Design: Written informed consent was obtained from each subject enrolled in the study. The Institutional Ethics Committee granted the ethical clearance for the study. Materials and Methods: This study included 20 patients diagnosed with chronic periodontitis. Pooled subgingival plaque samples were collected using sterile curettes from the deepest sites of periodontal pockets. The collected samples were then transported in 1 mL of reduced transport fluid. The organisms were cultured and confirmed. These organisms were then used for minimum inhibitory concentration (MIC) procedure. Statistical Analysis: Mean of the MIC value obtained was calculated. Results: Thirteen out of the 20 clinical samples were tested that showed sensitivity at various concentrations. Five samples showed sensitivity at all concentrations. Twelve samples showed sensitivity at 8 mcg/ml. Eleven samples showed sensitivity at 4 mcg/ml, 8 samples showed sensitivity at 2 mcg/ml, and 5 samples showed sensitivity even at 1 mcg/ml. Mean MIC value of G. lucidum spore powder for P. intermedia obtained was 3.62 mcg/ml. Conclusion: G. lucidum with its multipotential bioactivity could be used as an anti-microbial, in conjunction with conventional therapy in periodontal disease.http://www.contempclindent.org/article.asp?issn=0976-237X;year=2015;volume=6;issue=6;spage=248;epage=252;aulast=NayakAnaerobic bacteriaanti-microbial agentsGanoderma lucidumGram-negative bacteriaperiodontitisPrevotella intermedia
collection DOAJ
language English
format Article
sources DOAJ
author Ranganath N Nayak
P T Dixitraj
Aarati Nayak
Kishore Bhat
spellingShingle Ranganath N Nayak
P T Dixitraj
Aarati Nayak
Kishore Bhat
Evaluation of anti-microbial activity of spore powder of Ganoderma lucidum on clinical isolates of Prevotella intermedia: A pilot study
Contemporary Clinical Dentistry
Anaerobic bacteria
anti-microbial agents
Ganoderma lucidum
Gram-negative bacteria
periodontitis
Prevotella intermedia
author_facet Ranganath N Nayak
P T Dixitraj
Aarati Nayak
Kishore Bhat
author_sort Ranganath N Nayak
title Evaluation of anti-microbial activity of spore powder of Ganoderma lucidum on clinical isolates of Prevotella intermedia: A pilot study
title_short Evaluation of anti-microbial activity of spore powder of Ganoderma lucidum on clinical isolates of Prevotella intermedia: A pilot study
title_full Evaluation of anti-microbial activity of spore powder of Ganoderma lucidum on clinical isolates of Prevotella intermedia: A pilot study
title_fullStr Evaluation of anti-microbial activity of spore powder of Ganoderma lucidum on clinical isolates of Prevotella intermedia: A pilot study
title_full_unstemmed Evaluation of anti-microbial activity of spore powder of Ganoderma lucidum on clinical isolates of Prevotella intermedia: A pilot study
title_sort evaluation of anti-microbial activity of spore powder of ganoderma lucidum on clinical isolates of prevotella intermedia: a pilot study
publisher Wolters Kluwer Medknow Publications
series Contemporary Clinical Dentistry
issn 0976-237X
0976-2361
publishDate 2015-01-01
description Aim: This study aimed at evaluating the anti-microbial activity of spore powder of Ganoderma lucidum on Prevotella intermedia isolated from subgingival plaque from chronic periodontitis patients. Settings and Design: Written informed consent was obtained from each subject enrolled in the study. The Institutional Ethics Committee granted the ethical clearance for the study. Materials and Methods: This study included 20 patients diagnosed with chronic periodontitis. Pooled subgingival plaque samples were collected using sterile curettes from the deepest sites of periodontal pockets. The collected samples were then transported in 1 mL of reduced transport fluid. The organisms were cultured and confirmed. These organisms were then used for minimum inhibitory concentration (MIC) procedure. Statistical Analysis: Mean of the MIC value obtained was calculated. Results: Thirteen out of the 20 clinical samples were tested that showed sensitivity at various concentrations. Five samples showed sensitivity at all concentrations. Twelve samples showed sensitivity at 8 mcg/ml. Eleven samples showed sensitivity at 4 mcg/ml, 8 samples showed sensitivity at 2 mcg/ml, and 5 samples showed sensitivity even at 1 mcg/ml. Mean MIC value of G. lucidum spore powder for P. intermedia obtained was 3.62 mcg/ml. Conclusion: G. lucidum with its multipotential bioactivity could be used as an anti-microbial, in conjunction with conventional therapy in periodontal disease.
topic Anaerobic bacteria
anti-microbial agents
Ganoderma lucidum
Gram-negative bacteria
periodontitis
Prevotella intermedia
url http://www.contempclindent.org/article.asp?issn=0976-237X;year=2015;volume=6;issue=6;spage=248;epage=252;aulast=Nayak
work_keys_str_mv AT ranganathnnayak evaluationofantimicrobialactivityofsporepowderofganodermalucidumonclinicalisolatesofprevotellaintermediaapilotstudy
AT ptdixitraj evaluationofantimicrobialactivityofsporepowderofganodermalucidumonclinicalisolatesofprevotellaintermediaapilotstudy
AT aaratinayak evaluationofantimicrobialactivityofsporepowderofganodermalucidumonclinicalisolatesofprevotellaintermediaapilotstudy
AT kishorebhat evaluationofantimicrobialactivityofsporepowderofganodermalucidumonclinicalisolatesofprevotellaintermediaapilotstudy
_version_ 1725289287272890368